Prevalence of Metabolic-Associated Fatty Liver Disease in Mexico and Development of a Screening Tool: The MAFLD-S Score

Metabolic-associated fatty liver disease (MAFLD) is a leading cause of chronic liver disease. Nowadays, the prevalence of MAFLD in Mexico is unknown with no screening point-of-care tools. We aimed to estimate the prevalence of MAFLD in Mexico and to develop a score for MAFLD screening.

Read the full article here

Related Articles